batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Roche touts early giredestrant success 18 November 2025 Xoma turns its attention to Repare 17 November 2025 No new responses for Oric 14 November 2025 Kura gets a safety edge over Syndax 13 November 2025 Time is running out for the NRF2 mechanism 13 November 2025 Gilead fails outside triple negative 11 November 2025 UroGen's exit makes Agenus look smart 7 November 2025 Bad omens for BioNTech & Roche’s neoantigen project 5 November 2025 Load More